We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by Antique-Reference585. In this article, we will summarize the bulls’ thesis on RXRX. Recursion Pharmaceuticals, Inc.’s ...

Recursion has stumbled through an early test of its tech-enabled approach to drug discovery, reporting a hit on its phase 2 primary endpoint of safety and tolerability but failing to wow on the ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

This is a preview. Log in through your library . Abstract A type-structure of partial effective functionals over the natural numbers, based on a canonical enumeration of the partial recursive ...

Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature assets are not reflective of its current capabilities. Recursion probably needs to advance 5-10 ...

This is a preview. Log in through your library . Abstract The recursion theorem in abstract partially ordered algebras, such as operative spaces and others, is the most fundamental result of algebraic ...